TICKER INTELLIGENCE
NYSE/NASDAQ: TALK
2
Active Bills
0
Gov't Contracts
0
Congressional Trades
$TALK is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 2 active Congressional signals mentioning $TALK, including 2 bills. The legislative sentiment is currently mixed, with both supportive and challenging policy signals in play.
The ADAPT Act (S2356) is a zero-funding authorization bill that would expand Medicare/Medicaid/CHIP coverage to include supervised psychology trainees. It remains in early committee stage with minimal support. Recent rallies in UNH, HUM, and CVS (+41.6%, +35.86%, +15.55% over 30 days) are driven by unrelated factors such as the April 18 Executive Order on psychedelic therapies, not this bill. No actionable market impact.
HR7875 (POINTS Act of 2026) is a bill in the earliest legislative stage authorizing a grant program for gambling addiction services, but it has no appropriated funding and zero near-term market impact. The bill was introduced on 2026-03-09 and referred to committee with no further action. No publicly traded company is directly or materially affected at this stage.
Daily AI-analyzed alerts for Congressional activity affecting your portfolio.
Get Started →